Document Type

Article

Publication Date

12-2023

Comments

This article is the author's final published version in The Pediatric Infectious Disease Journal, Volume 42, Issue 12, December 2023, Pg. e490 - e492.

The published version is available at https://doi.org/10.1097/inf.0000000000004122. Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.

Abstract

In 2022, a surge in cases of pediatric human parechovirus (HPeV) central nervous system infections in young infants was seen at our institution. Despite the dramatic increase in the number of cases seen that year, the clinical features of the illness were similar to prior years. The recent pediatric HPeV surge highlights the need to evaluate treatment options and standardize follow-up to better understand the long-term prognosis of infants with HPeV infection.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

PubMed ID

37851979

Language

English

Share

COinS